9780309993821: Aligning Investments in Therapeutic Development with Therapeutic Need: Closing the Gap
Couverture souple
ISBN 10 : 0309993822 ISBN 13 : 9780309993821
Editeur : National Academies Press, 2025

Synopsis

The United States is a global leader in biomedical research, generating therapeutic breakthroughs that advance the health of the nation and the world. The public and private sectors contribute to this advancement by funding biomedical research and development. The current level of investment in pharmaceutical development in the United States, while substantial, does not always yield desired health outcomes or meet the needs of patients. Public and private funders face a myriad of challenges that affect their funding decisions and hinder the ability of the drug development system to prioritize disease burden and unmet need - often leaving critical gaps in available treatment options.

To better understand these gaps, Gates Ventures and the Peterson Center on Healthcare asked the National Academies to examine current challenges and offer strategies and recommendations for improvement. The resulting report emphasizes that current research prioritization does not systematically account for disease burden and unmet needs, and describes how a robust, timely, accessible data system is needed. It also explores the ways in which implementing recommended policy changes could deliver better health outcomes.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Éditeur
National Academies Press
Date d'édition
2025
Langue
anglais
ISBN 10 
0309993822
ISBN 13 
9780309993821
Reliure
Broché
Nombre de pages
246
Éditeur
Schumm Samantha, Helman Alex, MacKenzie Ellen, Berwick Donald
Coordonnées du fabricant
non disponible
Personne responsable
non disponible